everything < evidence < evidenced

Facettes :

List of bibliographic references indexed by evidence

Number of relevant bibliographic references: 126.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000080 (2015)	F S Sprenger [Autriche] ; K. Seppi [Autriche] ; A. Djamshidian [Autriche] ; E. Reiter [Autriche] ; M. Nocker [Autriche] ; K. Mair [Autriche] ; G. Göbel [Autriche] ; Werner Poewe [Autriche]	Reply: Nonmotor symptoms in subjects without evidence of dopaminergic deficits.
000143 (2015)	Fabienne S. Sprenger [Autriche] ; Klaus Seppi [Autriche] ; Atbin Djamshidian [Autriche] ; Eva Reiter [Autriche] ; Michael Nocker [Autriche] ; Katherina Mair [Autriche] ; Georg Göbel [Autriche] ; Werner Poewe [Autriche]	Nonmotor symptoms in subjects without evidence of dopaminergic deficits.
000146 (2015)	Matthew E. Gegg [Royaume-Uni] ; Lindsay Sweet [États-Unis] ; Bing H. Wang [États-Unis] ; Lamya S. Shihabuddin [États-Unis] ; Sergio Pablo Sardi [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni]	No Evidence for Substrate Accumulation in Parkinson Brains With GBA Mutations
000448 (2014)	Wataru Sako [États-Unis] ; Nagahisa Murakami ; Yuishin Izumi ; Ryuji Kaji	Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
000483 (2014)	Amit Batla [Royaume-Uni] ; Roberto Erro ; Maria Stamelou ; Susanne A. Schneider ; Petra Schwingenschuh ; Christos Ganos ; Kailash P. Bhatia	Patients with scans without evidence of dopaminergic deficit: a long-term follow-up study.
000528 (2014)	Davide Chiasserini [Italie] ; Emanuele Persichetti ; Silvia Paciotti ; Tommaso Beccari ; Lucilla Parnetti	Lysosomal enzymes in PD: further evidence is needed.
000566 (2014)	Talia Herman [Israël] ; Keren Rosenberg-Katz ; Yael Jacob ; Nir Giladi ; Jeffrey M. Hausdorff	Gray matter atrophy and freezing of gait in Parkinson's disease: Is the evidence black-on-white?
000587 (2014)	Benjamin Dehay [France]	Evidence piles Up for prion-like propagation mechanisms in synucleinopathies.
000613 (2014)	Annie Killoran [États-Unis] ; Kevin M. Biglan	Current therapeutic options for Huntington's disease: good clinical practice versus evidence-based approaches?
000757 (2013)	André Lee [Allemagne] ; Kenta Tominaga ; Shinichi Furuya ; Fumio Miyazaki ; Eckart Altenmüller	Task-specific tremor in violinists: evidence of coactivation in the 3 to 8 Hz frequency range.
000840 (2013)	Olivier Rascol	Physical exercise in Parkinson disease: moving toward more robust evidence?
000845 (2013)	Ralf Reilmann [Allemagne]	Pharmacological treatment of chorea in Huntington’s disease–good clinical practice versus evidence-based guideline
000857 (2013)	Karl Kieburtz [États-Unis] ; Kathryn B. Wunderle	Parkinson's disease: evidence for environmental risk factors.
000890 (2013)	Roberto Ceravolo [Italie] ; Giovanni Cossu ; Monica Bandettini Di Poggio ; Lucio Santoro ; Paolo Barone ; Maurizio Zibetti ; Daniela Frosini ; Valentina Nicoletti ; Fiore Manganelli ; Rosa Iodice ; Marina Picillo ; Aristide Merola ; Leonardo Lopiano ; Alessandra Paribello ; Davide Manca ; Maurizio Melis ; Roberta Marchese ; Paolo Borelli ; Alessandra Mereu ; Paolo Contu ; Giovanni Abbruzzese ; Ubaldo Bonuccelli	Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.
000A19 (2013)	David E. Vaillancourt [États-Unis] ; Daniel Schonfeld [États-Unis] ; Youngbin Kwak [États-Unis] ; Nicolaas I. Bohnen [États-Unis] ; Rachael Seidler [États-Unis]	Dopamine overdose hypothesis: Evidence and clinical implications
000A60 (2013)	Marianna Amboni [Italie] ; Paolo Barone [Italie] ; Jeffrey M. Hausdorff [Israël, États-Unis]	Cognitive Contributions to Gait and Falls: Evidence and Implications
000C87 (2012)	Julia Richter ; Silke Appenzeller ; Ole Ammerpohl ; G. Deuschl ; Steffen Paschen ; Norbert Brüggemann ; Christine Klein ; Gregor Kuhlenb Umer	No evidence for differential methylation of α-synuclein in leukocyte DNA of Parkinson's disease patients.
000D39 (2012)	Kathleen M. Shannon [États-Unis] ; Ali Keshavarzian ; Hemraj B. Dodiya ; Shriram Jakate ; Jeffrey H. Kordower	Is alpha-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases.
000D83 (2012)	Alison Yarnall [Royaume-Uni]	Further evidence that amyloid-β oligomer and cellular prion protein interaction produces deleterious consequences in Alzheimer's disease.
000D96 (2012)	Helen Michelakakis [Grèce] ; Georgia Xiromerisiou ; Efthimios Dardiotis ; Maria Bozi ; Demetrios Vassilatis ; Persa-Maria Kountra ; Gianna Patramani ; Marina Moraitou ; Dimitra Papadimitriou ; Eleftherios Stamboulis ; Leonidas Stefanis ; Elias Zintzaras ; Georgios M. Hadjigeorgiou	Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.
000E28 (2012)	María T. Cáceres-Redondo ; Fátima Carrillo ; Francisco J. Palomar ; Pablo Mir	DYT-1 gene dystonic tremor presenting as a "scan without evidence of dopaminergic deficit".

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "evidence" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "evidence" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    evidence
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024